Literature DB >> 23998045

Evaluation of glycated albumin and microalbuminuria as early risk markers of nephropathy in type 2 diabetes mellitus.

Suresh Babu Kondaveeti1, Kumaraswamy D, Shishir Mishra, Aravind Kumar R, I Anand Shaker.   

Abstract

INTRODUCTION: Since Glycated Albumin (GA) reflects short term variations and glycated protein shows degrees of hyperglycaemia, the objective of this study was to find GA and microalbuminuria as a early risk markers along with the duration of Uncontrolled Diabetes Mellitus in type 2 diabetic nephropathy.
MATERIAL AND METHODS: The present cross-sectional study included randomly selected Uncontrolled Type 2DM (n = 75), controlled Type 2DM (n = 75) and healthy controls (n = 75). Their fasting venous blood samples were obtained for GA and serum creatinine, while their morning urine samples were obtained for detection of microalbuminuria. Statistical analysis was done by using SPSS, version 16.0. One-Way ANOVA was performed. All p-values which were ≤ 0.05 were considered as statistically significant.
RESULTS: The mean GA, microalbuminuria and serum creatinine were the highest in Uncontrolled DM as compared to those in Controlled DM respectively. Microalbuminuria and GA had a significant correlation with the duration of diabetes (p<0.0001).
CONCLUSION: The present study identified that the risk of microalbuminuria increased with a poor glycaemic control. A persistent increase in GA and microalbuminuria may be considered as risk markers in diabetic nephropathy. Therefore, a regular screening for microalbuminuria and estimation of GA can help in the clinical management, to prevent complications.

Entities:  

Keywords:  Diabetic nephropathy; Glycated albumin; Microalbuminuria

Year:  2013        PMID: 23998045      PMCID: PMC3749615          DOI: 10.7860/JCDR/2013/5145.3117

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  14 in total

Review 1.  The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. A systematic overview of the literature.

Authors:  S F Dinneen; H C Gerstein
Journal:  Arch Intern Med       Date:  1997-07-14

2.  Report of the expert committee on the diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

3.  Study of glycated amino acid elimination reaction for an improved enzymatic glycated albumin measurement method.

Authors:  Takuji Kouzuma; Yumiko Uemastu; Tomomi Usami; Shigeyuki Imamura
Journal:  Clin Chim Acta       Date:  2004-08-16       Impact factor: 3.786

4.  Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control.

Authors:  Satomi Takahashi; Hiroshi Uchino; Tomoaki Shimizu; Akio Kanazawa; Yoshifumi Tamura; Ken Sakai; Hirotaka Watada; Takahisa Hirose; Ryuzo Kawamori; Yasushi Tanaka
Journal:  Endocr J       Date:  2006-12-11       Impact factor: 2.349

5.  A comparison of the Glycosylation Gap and Hemoglobin Glycation Index in patients with diabetes.

Authors:  Stuart A Chalew; Robert J McCarter; Jacinta Thomas; Jessica L Thomson; James M Hempe
Journal:  J Diabetes Complications       Date:  2005 Jul-Aug       Impact factor: 2.852

Review 6.  Extracellular matrix metabolism in diabetic nephropathy.

Authors:  Roger M Mason; Nadia Abdel Wahab
Journal:  J Am Soc Nephrol       Date:  2003-05       Impact factor: 10.121

7.  Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study.

Authors:  C E Mogensen; S Neldam; I Tikkanen; S Oren; R Viskoper; R W Watts; M E Cooper
Journal:  BMJ       Date:  2000-12-09

8.  [Intensified conventional insulin therapy in patients with type 2 diabetes mellitus. Positive long-term effects of insulin lispro on metabolic control and microalbuminuria].

Authors:  E Jungmann; T Helling; G Jungmann; C Mertens; U Snelting
Journal:  Fortschr Med Orig       Date:  2001-01-11

9.  Indicators for blood glucose control in diabetics with end-stage chronic renal disease: GHb vs. glycated albumin (GA).

Authors:  Keiko Chujo; Kenji Shima; Hiroaki Tada; Teruyo Oohashi; Jun Minakuchi; Syu Kawashima
Journal:  J Med Invest       Date:  2006-08

10.  Progression to microalbuminuria in type 1 diabetes: development and validation of a prediction rule.

Authors:  Y Vergouwe; S S Soedamah-Muthu; J Zgibor; N Chaturvedi; C Forsblom; J K Snell-Bergeon; D M Maahs; P-H Groop; M Rewers; T J Orchard; J H Fuller; K G M Moons
Journal:  Diabetologia       Date:  2009-11-04       Impact factor: 10.122

View more
  9 in total

1.  Microangiopathy is common in submucosal vessels of the colon in patients with diabetes mellitus.

Authors:  Agata Sasor; Bodil Ohlsson
Journal:  Rev Diabet Stud       Date:  2014-08-10

Review 2.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

3.  Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.

Authors:  Christine L Chan; Laura Pyle; Megan M Kelsey; Lindsey Newnes; Amy Baumgartner; Philip S Zeitler; Kristen J Nadeau
Journal:  Pediatr Diabetes       Date:  2016-11-22       Impact factor: 4.866

Review 4.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

5.  Glycated albumin and the risk of micro- and macrovascular complications in subjects with type 1 diabetes.

Authors:  Hye-jin Yoon; Yong-ho Lee; So Ra Kim; Tyler Hyungtaek Rim; Eun Young Lee; Eun Seok Kang; Bong-soo Cha; Hyun Chul Lee; Byung-wan Lee
Journal:  Cardiovasc Diabetol       Date:  2015-05-15       Impact factor: 9.951

6.  Use of auricular acupressure to improve the quality of life in diabetic patients with chronic kidney diseases: a prospective randomized controlled trial.

Authors:  Shaoqing Wang; Zhaohui Chen; Ping Fu; Li Zang; Li Wang; Xi Zhai; Fang Gao; Aijing Huang; Yao Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2014-12-10       Impact factor: 2.629

7.  Glycated Albumin Is a More Useful Glycation Index than HbA1c for Reflecting Renal Tubulopathy in Subjects with Early Diabetic Kidney Disease.

Authors:  Ji Hye Huh; Minyoung Lee; So Young Park; Jae Hyeon Kim; Byung Wan Lee
Journal:  Diabetes Metab J       Date:  2018-05-02       Impact factor: 5.376

8.  Anemia modifies the prognostic value of glycated hemoglobin in patients with diabetic chronic kidney disease.

Authors:  I-Ching Kuo; Hugo You-Hsien Lin; Sheng-Wen Niu; Jia-Jung Lee; Yi-Wen Chiu; Chi-Chih Hung; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2018-06-22       Impact factor: 3.240

9.  Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.

Authors:  Cyrus V Desouza; Richard G Holcomb; Julio Rosenstock; Juan P Frias; Stanley H Hsia; Eric J Klein; Rong Zhou; Takuji Kohzuma; Vivian A Fonseca
Journal:  J Clin Endocrinol Metab       Date:  2020-03-01       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.